Body Systems

Heart Disease9 Results found

Studies recruiting participants:

Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation (RAFT-PermAF)

Atrial fibrillation (AF) and heart failure (HF) are two common heart conditions that are encountered with an increase in death and suffering. When both these two conditions occur in a patient, the patient's prognosis is poor with a reduced quality of life.

Recruiting
Principal Investigator 
Matthew Bennett
Body Locations and Systems 
Heart Failure, Atrial Fibrillation, Heart Disease
Area 
Vancouver
Age 
18 and above

Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure (PRIORITIZE HF)

This is an international, multicentre, parallel-group, randomised, double-blind, placebo controlled, phase II study to evaluate the benefits and risks of using sodium zirconium cyclosilicate (ZS) to initiate and intensify renin angiotensin aldosterone system inhibitor (RAASi) therapy in heart fai

Recruiting
Principal Investigator 
Lynn Straatman
Body Locations and Systems 
Heart Failure, Heart Disease
Area 
Vancouver
Age 
18 and above

Closed for recruitment:

EXCEL Clinical Trial (EXCEL)

To establish the safety and efficacy of the commercially approved XIENCE Family Stent System (inclusive of XIENCE PRIME, XIENCE V, XIENCE Xpedition and XIENCE PRO [for use outside the United States [OUS] only]) in subjects with unprotected left main coronary artery disease by comparing to coronar

Closed for Recruitment
Principal Investigator 
Jaap N. Hamburger
Body Locations and Systems 
Heart Disease, Coronary Artery Disease
Area 
Vancouver
Age 
18 and above